The Hematology Podcast
|
Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders. This podcast covers cutting-edge research, clinical advancements, and real-world cases tailored for healthcare professionals. Each episode offers expert perspectives on evolving therapies and best practices, helping you stay informed and improve patient outcomes. Whether you're focused on research or clinical practice, The Hematology Podcast is designed to keep you at the forefront of the field, transforming your approach to hematology. |
The Hematology Podcast
SEASON 5 |
The Hematology Podcast
SEASON 4 |
The Hematology Podcast
SEASON 3 |
The Hematology Podcast
SEASON 2 |
The Hematology Podcast
SEASON 1 |
Get to know the host
In each episode, Dr. Mats Merup leads the interviews with the respective experts, providing a deep dive into the clinical, theoretical and practical aspects of the hematological field.
Associate professor Mats Merup, MD PhD (host)
Hematologist
Stockholm, Sweden
Mats Merup is an experienced clinical hematologist with an MD and PhD, specializing in malignant lymphomas and myeloproliferative disorders. He currently works in the clinical setting and has contributed to 50 published research publications as a clinical researcher.
Other channels to subscribe
The Hematology Podcast
Don’t miss the next episode, go to your favorite player and subscribe to the podcast
For additional insights and resources in hematology, refer to the following sites
Gerelateerde paginas
Gaucher disease in children
Gaucher disease is an autosomal recessive lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, resulting in deficient activity of the enzyme acid β glucosidase.
Defining ITP
Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5
Mechanism of Disease
Complex immune dysregulation can lead to autoimmunity and inflammation1-6